StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
17
Publishing Date
2023 - 12 - 29
1
2023 - 11 - 18
1
2023 - 11 - 17
1
2023 - 10 - 13
1
2022 - 12 - 16
1
2022 - 12 - 09
1
2022 - 11 - 18
2
2022 - 10 - 08
1
2022 - 04 - 30
1
2022 - 04 - 29
1
2022 - 03 - 12
1
2022 - 01 - 21
1
2021 - 12 - 17
1
2021 - 11 - 19
1
2021 - 10 - 01
1
2021 - 05 - 21
1
Sector
Consumer non-durables
1
Finance
1
Finance and insurance
2
Health technology
12
Industrial services
1
Mining, quarrying, and oil and gas extraction
1
N/a
2
Tags
Active
1
Adhd
1
Approval
11
Authorized
1
Bracanalysis
1
Breast cancer
1
Cancer
2
Car-t
1
Corporation
1
Covid
1
Device
1
Diagnostic
1
Drug
2
Extension
1
Fda
9
Fda approval
2
Fda-approvals
5
Financial
1
Food
2
Genetic
1
Hypertension
1
Infections
1
Leukemia
1
Lynparza
1
Major depressive disorder
1
Meeting
1
N/a
12
Orgovyx
1
Pharmaceuticals
1
Prostate cancer
1
Qelbree
1
Risankizumab
1
Rylaze
1
Security
1
Skyrizi
1
T-cell
1
Treat
1
Treatment
4
Vaccine
1
Vraylar
1
Xerava
1
Entities
Abbvie inc.
2
Argenx se
1
Bactech environmental corp
1
Bancorp 34, inc.
1
Cal-maine foods, inc.
1
Centric financial corp
1
Contango ore, inc.
1
First commonwealth financial corporation
1
Gigcapital5, inc.
1
Gilead sciences, inc.
1
Jazz pharmaceuticals plc
1
La jolla pharmaceutical company
1
Medtronic plc
1
Moderna, inc.
1
Mount rainier acquisition corp.
1
Myovant sciences ltd.
1
Myriad genetics, inc.
1
Pegasus digital mobility acquisition corp.
1
Pfizer, inc.
1
Revelstone capital acquisition corp.
1
Supernus pharmaceuticals, inc.
1
Zai lab limited
1
Symbols
ABBV
2
ARGX
1
BCCEF
1
BCTF
1
CALM
1
CFCX
1
CTGO
1
FCF
1
GIA
1
GILD
1
JAZZ
1
LJPC
1
MDT
1
MRNA
1
MYGN
1
MYOV
1
PFE
1
PGSS
1
RCAC
1
RNER
1
SUPN
1
ZLAB
1
Exchanges
Nasdaq
12
Nyse
6
Crawled Date
2023 - 12 - 30
1
2023 - 11 - 19
1
2023 - 11 - 18
1
2023 - 10 - 14
1
2022 - 12 - 17
1
2022 - 12 - 10
1
2022 - 11 - 19
2
2022 - 10 - 08
1
2022 - 04 - 30
2
2022 - 03 - 12
1
2022 - 01 - 22
1
2021 - 12 - 18
1
2021 - 11 - 20
1
2021 - 10 - 02
1
2021 - 05 - 22
1
Crawled Time
00:00
99
00:01
3
00:12
2
00:20
17
01:00
64
02:00
23
03:00
20
04:00
14
04:20
15
05:00
19
06:00
49
07:00
49
07:01
2
08:00
45
08:20
6
09:00
65
10:00
60
10:41
3
11:00
160
12:00
367
12:01
3
12:02
2
12:03
4
12:05
2
12:07
5
12:15
31
12:20
83
12:30
70
13:00
331
13:01
4
13:02
2
13:03
10
13:05
2
13:15
18
13:20
73
13:30
85
13:47
5
14:00
267
14:01
4
14:15
8
14:20
43
14:30
58
15:00
163
15:15
14
15:20
32
15:30
47
16:00
97
16:20
6
17:00
142
18:00
125
19:00
132
20:00
158
21:00
283
21:03
3
21:06
3
22:00
254
22:01
7
22:03
3
22:07
3
23:00
173
Source
feed.businesswire.com
1
spacfeed.com
1
www.bactechgreen.com
1
www.biospace.com
5
www.globenewswire.com
5
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
crawled time :
00:20
save search
GigCapital5, Inc. Announces Stockholder Approval of Extension … – Yahoo Finance
Published:
2023-12-29
(Crawled : 00:20)
- spacfeed.com
BCTF
|
$9.38
500
|
Finance and Insurance
|
Email alert
Add to watchlist
CALM
|
$60.7
-1.94%
340K
|
Consumer Non-Durables
|
Email alert
Add to watchlist
GIA
|
$1.08
237.96%
1.4K
|
|
Email alert
Add to watchlist
RCAC
|
$10.74
0.0%
2.7K
|
n/a
|
Email alert
Add to watchlist
PGSS
|
$10.57
-7.28%
16K
|
n/a
|
Email alert
Add to watchlist
approval
extension
BacTech Environmental Receives Final ESIA Permit Approval from Ecuadorian Government to Begin Development of Bioleach Processing Facility in Tenguel
Published:
2023-11-18
(Crawled : 00:20)
- bactechgreen.com
BCCEF
|
$0.0552
43K
|
Industrial Services
|
Email alert
Add to watchlist
approval
Medtronic announces FDA approval of minimally invasive device to treat hypertension
Published:
2023-11-17
(Crawled : 00:20)
- prnewswire.com
MDT
|
$79.1
-0.19%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
fda
device
approval
treat
hypertension
U.S. FDA Approves Pfizer’s VELSIPITY™ for Adults with Moderately to Severely Active Ulcerative Colitis (UC)
Published:
2023-10-13
(Crawled : 00:20)
- biospace.com/
PFE
A
|
$25.475
-0.84%
35M
|
Health Technology
|
-21.96%
|
O:
0.06%
H:
0.15%
C:
-2.52%
fda
active
U.S. FDA Approves VRAYLAR® (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder
Published:
2022-12-16
(Crawled : 00:20)
- prnewswire.com
ABBV
|
$164.24
1.05%
1.8M
|
Health Technology
|
Email alert
Add to watchlist
vraylar
treatment
fda
major depressive disorder
HUB Cyber Security and Mount Rainier Announce Registration Statement Effectiveness and Special Meeting Date to Approve Business Combination
Published:
2022-12-09
(Crawled : 00:20)
- prnewswire.com
RNER
|
$4.99
20.24%
0
|
n/a
|
Email alert
Add to watchlist
meeting
security
Jazz Pharmaceuticals Announces U.S. FDA Approval of Monday/Wednesday/Friday Intramuscular Dosing Schedule for Rylaze® (asparaginase erwinia chrysanthemi (recombinant)-rywn)
Published:
2022-11-18
(Crawled : 00:20)
- biospace.com/
JAZZ
|
$106.895
-1.84%
330K
|
Health Technology
|
-24.96%
|
O:
0.85%
H:
1.29%
C:
0.56%
rylaze
fda
pharmaceuticals
approval
First Commonwealth Financial Corporation Receives Regulatory Approval for Centric Financial Corporation Merger
Published:
2022-11-18
(Crawled : 00:20)
- globenewswire.com
FCF
|
$12.7
1.36%
190K
|
Finance
|
Email alert
Add to watchlist
CFCX
|
$15.95
0
|
Finance and Insurance
|
Email alert
Add to watchlist
approval
corporation
financial
Everest Medicines Announces Approval of XERAVA® in Hong Kong for the Treatment of Complicated Intra-Abdominal Infections
Published:
2022-10-08
(Crawled : 00:20)
- prnewswire.com
LJPC
|
$6.22
0.0%
|
Health Technology
|
Email alert
Add to watchlist
xerava
treatment
infections
approval
Myovant Sciences Announces European Commission Approval for ORGOVYX® (relugolix) for the Treatment of Advanced Hormone-Sensitive Prostate Cancer
Published:
2022-04-29
(Crawled : 00:20)
- globenewswire.com
MYOV
|
$26.98
-0.04%
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
orgovyx
treatment
approval
cancer
prostate cancer
Supernus Announces FDA Approval of Qelbree® for the Treatment of ADHD in Adults
Published:
2022-04-30
(Crawled : 00:20)
- globenewswire.com
SUPN
|
$29.62
0.65%
110K
|
Health Technology
|
Email alert
Add to watchlist
qelbree
treatment
fda
adhd
approval
Myriad Genetics Receives FDA Approval of BRACAnalysis® CDx as a Companion Diagnostic for Lynparza® in Early Breast Cancer
Published:
2022-03-12
(Crawled : 00:20)
- globenewswire.com
MYGN
F
|
$18.645
-1.45%
240K
|
Health Technology
|
Email alert
Add to watchlist
bracanalysis
diagnostic
fda
genetic
lynparza
fda approval
approval
cancer
breast cancer
U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis
Published:
2022-01-21
(Crawled : 00:20)
- biospace.com/
ABBV
|
$164.24
1.05%
1.8M
|
Health Technology
|
20.96%
|
O:
-0.83%
H:
0.0%
C:
0.0%
skyrizi
fda
risankizumab
Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
Published:
2021-12-17
(Crawled : 00:20)
- globenewswire.com
ARGX
|
$367.01
-0.99%
170K
|
Health Technology
|
Email alert
Add to watchlist
ZLAB
|
$13.93
-3.4%
210K
|
Health Technology
|
Email alert
Add to watchlist
fda
drug
approval
food
Contango ORE Announces Approval to List on the NYSE American
Published:
2021-11-19
(Crawled : 00:20)
- feed.businesswire.com
CTGO
4
|
$20.4
-3.86%
11K
|
Mining, Quarrying, and Oil and ...
|
Email alert
Add to watchlist
approval
U.S. FDA Approves Kite’s Tecartus® as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Published:
2021-10-01
(Crawled : 00:20)
- biospace.com/
GILD
|
$67.18
-0.19%
2.5M
|
Health Technology
|
-3.64%
|
O:
-1.29%
H:
0.0%
C:
0.0%
fda
leukemia
fda approval
car-t
t-cell
Ministry of Food and Drug Safety of South Korea (MFDS) Authorizes Moderna’s COVID-19 Vaccine
Published:
2021-05-21
(Crawled : 00:20)
- biospace.com/
MRNA
S
|
$102.82
-0.94%
1.1M
|
Health Technology
|
-37.46%
|
O:
1.78%
H:
0.21%
C:
-4.43%
covid
food
vaccine
drug
authorized
Gainers vs Losers
63%
37%
Top 10 Gainers
INVO
|
$2.78
265.79%
200M
|
Health Technology
EDBL
|
$7.4
62.64%
12M
|
RYDE
|
$3.89
42.49%
1.2M
|
n/a
GRTX
|
$0.237
39.41%
13M
|
Health Technology
VNDA
|
$5.28
30.37%
21M
|
Health Technology
VIRX
|
$0.912
27.59%
170K
|
Manufacturing
WISA
4
|
$7.72
26.56%
51M
|
Electronic Technology
LUXH
|
$1.045
26.06%
540K
|
RCAT
|
$1.41
25.89%
3.2M
|
Information
TCON
|
$2.135
24.85%
440K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.